MetaADEDB 2.0 @ LMMD
Acamprosate
(AFCGFAGUEYAMAO-UHFFFAOYSA-N)
Structure
SMILES
CC(=O)NCCCS(=O)(=O)O
Type(s)
Approved; Investigational
ATC code(s)
N07BB03
Molecular Formula:
C5H11NO4S
Molecular Weight:
181.210
Log P:
0.8721
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
91.85
CAS Number(s):
77337-76-9
Synonym(s)
1.
Acamprosate
2.
Acamprosate Calcium
3.
Acamprostate
4.
Aotal
5.
Calcium Acetyl Homotaurinate
6.
Calcium Acetylhomotaurinate
7.
Calcium Acetylhomotaurine
8.
Campral
9.
Campral EC
10.
N-Acetylhomotaurine
11.
N-Acetylhomotaurine, Calcium (2:1) Salt
12.
N-Acetylhomotaurine, Magnesium (2:1) Salt
13.
N-Acetylhomotaurine, Monolithium Salt
14.
N-Acetylhomotaurine, Monopotassium Salt
15.
N-Acetylhomotaurine, Monosodium Salt
16.
N-Acetylhomotaurine, Zinc (2:1) Salt
17.
Regtect
18.
Sodium Acetylhomotaurine
19.
Zulex
20.
Acetyl Homotaurinate, Calcium
21.
Acetylhomotaurinate, Calcium
22.
Acetylhomotaurine, Calcium
23.
Acetylhomotaurine, Sodium
24.
N Acetylhomotaurine
25.
N Acetylhomotaurine, Monolithium Salt
26.
N Acetylhomotaurine, Monopotassium Salt
27.
N Acetylhomotaurine, Monosodium Salt
External Link(s)
MeSHD000077443
PubChem Compound71158
ChEBI51041
CHEMBLCHEMBL1201293
DrugBankDB00659
DrugCentral38
IUPHAR/BPS Guide to PHARMACOLOGY7106
KEGGdr:D07058
Therapeutic Target DatabaseD0GC2M
ZINC1554588
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
2VomitingFAERS: 5SIDER
US FAERS
3Drug screen false positiveFAERS: 4US FAERS
4Abdominal PainFAERS: 3SIDER
US FAERS
5HeadacheFAERS: 3SIDER
US FAERS
6HypersensitivityFAERS: 3SIDER
US FAERS
7HypotensionFAERS: 3SIDER
US FAERS
8TachycardiaFAERS: 3SIDER
US FAERS
9AscitesFAERS: 2SIDER
US FAERS
10AstheniaFAERS: 2SIDER
US FAERS
11Burning sensationFAERS: 2US FAERS
12Cerebral InfarctionFAERS: 2US FAERS
13DizzinessFAERS: 2SIDER
US FAERS
14Drug exposure during pregnancyFAERS: 2US FAERS
15Feeling abnormalFAERS: 2SIDER
US FAERS
16FlatulenceFAERS: 2OFFSIDES
SIDER
US FAERS
17MalaiseFAERS: 2SIDER
US FAERS
18NauseaFAERS: 2SIDER
US FAERS
19Therapeutic response unexpectedFAERS: 2US FAERS
20UrticariaFAERS: 2SIDER
US FAERS
21Weight decreasedFAERS: 2SIDER
US FAERS
22Accidental overdoseFAERS: 1US FAERS
23Alcohol abuseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
24Alcohol interactionFAERS: 1US FAERS
25Alcohol poisoningFAERS: 1US FAERS
26AmnesiaFAERS: 1SIDER
US FAERS
27AnxietyFAERS: 1SIDER
US FAERS
28AphagiaFAERS: 1US FAERS
29ArthralgiaFAERS: 1SIDER
US FAERS
30ArthritisFAERS: 1SIDER
US FAERS
31Blood alcohol increasedFAERS: 1US FAERS
32ChillsFAERS: 1SIDER
US FAERS
33ChromaturiaFAERS: 1US FAERS
34Completed SuicideFAERS: 1US FAERS
35ConstipationFAERS: 1SIDER
US FAERS
36Deep Vein ThrombosisFAERS: 1US FAERS
37DehydrationFAERS: 1US FAERS
38Disease recurrenceFAERS: 1OFFSIDES
US FAERS
39DiverticulitisFAERS: 1US FAERS
40Drug exposure via breast milkFAERS: 1US FAERS
41Drug screen positiveFAERS: 1OFFSIDES
US FAERS
42ErythemaFAERS: 1US FAERS
43FatigueFAERS: 1US FAERS
44GoutFAERS: 1SIDER
US FAERS
45Hepatic EncephalopathyFAERS: 1US FAERS
46Hepatitis CFAERS: 1US FAERS
47HepatitisFAERS: 1OFFSIDES
SIDER
US FAERS
48HypophagiaFAERS: 1US FAERS
49IncontinenceFAERS: 1OFFSIDES
US FAERS
50InfectionFAERS: 1SIDER
US FAERS
51Joint swellingFAERS: 1US FAERS
52Laboratory test interferenceFAERS: 1US FAERS
53MyalgiaFAERS: 1SIDER
US FAERS
54Myocardial InfarctionFAERS: 1SIDER
US FAERS
55Optic NeuritisFAERS: 1OFFSIDES
US FAERS
56OverdoseFAERS: 1US FAERS
57PainFAERS: 1SIDER
US FAERS
58PetechiaeFAERS: 1US FAERS
59PruritusFAERS: 1SIDER
US FAERS
60Reaction to preservativesFAERS: 1US FAERS
61RestlessnessFAERS: 1US FAERS
62Status EpilepticusFAERS: 1US FAERS
63StressFAERS: 1US FAERS
64Sudden deathFAERS: 1SIDER
US FAERS
65Sudden infant death syndromeFAERS: 1US FAERS
66Suicide attemptFAERS: 1SIDER
US FAERS
67TinnitusFAERS: 1OFFSIDES
SIDER
US FAERS
68TremorFAERS: 1SIDER
US FAERS
69Unresponsive to stimuliFAERS: 1US FAERS
70jaundiceFAERS: 1US FAERS
71Abnormal ejaculationSIDER
72Abnormal visionSIDER
73AbscessSIDER
74Acute Coronary SyndromeSIDER
75AgitationSIDER
76Alanine Aminotransferase IncreasedSIDER
77Alcoholic Intoxication15608650CTD
78AlopeciaSIDER
79AmblyopiaSIDER
80Anaphylactic shockSIDER
81Angina PectorisSIDER
82AngioedemaSIDER
83AnhidrosisOFFSIDES
84AnorexiaOFFSIDES
SIDER
85AnorgasmiaOFFSIDES
86Anticonvulsant drug level below therapeuticOFFSIDES
87Anticonvulsant drug level decreasedOFFSIDES
88Anxiety Disorders28616095CTD
89Aortic AneurysmOFFSIDES
90ApathySIDER
91Aspartate Aminotransferase IncreasedSIDER
92AsthmaSIDER
93Atrial FlutterOFFSIDES
94AuraOFFSIDES
95AvitaminosisSIDER
96Back PainSIDER
97BiopsyOFFSIDES
98BlepharospasmOFFSIDES
99Blood alkaline phosphatase increasedSIDER
100Blood chloride decreasedOFFSIDES
101Blood creatine phosphokinase MB increasedOFFSIDES
102Blood creatinine increasedSIDER
103Blood folate increasedOFFSIDES
104Blood glucose decreasedOFFSIDES
105Blood lactate dehydrogenase increasedSIDER
106Blood magnesium decreasedOFFSIDES
107Blurred visionOFFSIDES
108Brain Ischemia11076270CTD
109BronchitisSIDER
110Cardiac enzymes increasedOFFSIDES
111Cardioactive drug levelOFFSIDES
112Chest PainSIDER
113CholangiolitisOFFSIDES
114CholecystitisSIDER
115Chronic ulcerative colitisOFFSIDES
116ClaustrophobiaOFFSIDES
117Cleft PalateOFFSIDES
118Cocaine-Related Disorders16914955
17764007
CTD
119Cogwheel RigidityOFFSIDES
120ColitisSIDER
121ConfabulationOFFSIDES
122Conversion disorderOFFSIDES
123Corneal erosionOFFSIDES
124Corneal thinningOFFSIDES
125Cramps of lower extremitiesSIDER
126Creatinine increasedSIDER
127Deafness NeurosensoryOFFSIDES
128DeafnessSIDER
129Depression suicidalOFFSIDES
130DermatitisSIDER
131Diabetes MellitusSIDER
132DiarrheaOFFSIDES
133DiplopiaSIDER
134DiscomfortSIDER
135Disturbance in sexual arousalSIDER
136Dry skinSIDER
137Duodenal UlcerSIDER
138DysgeusiaSIDER
139DysmorphismOFFSIDES
140DyspepsiaSIDER
141DysphemiaOFFSIDES
142Dysthymic DisorderOFFSIDES
143EcchymosisSIDER
144EczemaSIDER
145EndophthalmitisSIDER
146Enlargement abdomenSIDER
147EnterocolitisOFFSIDES
148EosinophiliaSIDER
149EpistaxisSIDER
150Erectile dysfunctionOFFSIDES
SIDER
151EructationSIDER
152Feeding tube complicationOFFSIDES
153Female sexual arousal disorderSIDER
154Flat affectSIDER
155Flight of ideasOFFSIDES
156FractureSIDER
157FrigiditySIDER
158Gamma-Glutamyltransferase IncreasedOFFSIDES
159Gastric ulcerSIDER
160GastritisSIDER
161GastroenteritisSIDER
162Gastrointestinal PainSIDER
163Hepatitis BOFFSIDES
164HerniaSIDER
165HostilitySIDER
166HyperkinesiaSIDER
167HypothyroidismSIDER
168HysterectomyOFFSIDES
169Iliac artery stenosisOFFSIDES
170Increased bronchial secretionOFFSIDES
171InfluenzaSIDER
172Injection site erythemaOFFSIDES
173Intentional injurySIDER
174Intentional misuseOFFSIDES
175Intentional self-injuryOFFSIDES
176Intermittent ClaudicationOFFSIDES
177Joint injuryOFFSIDES
178LacerationOFFSIDES
179Lactic dehydrogenase activity increasedSIDER
180LaryngospasmSIDER
181LeukoencephalopathyOFFSIDES
182LeukopeniaSIDER
183Lichen PlanusOFFSIDES
184Lip erosionOFFSIDES
185Lymph nodes scan abnormalOFFSIDES
186LymphadenopathySIDER
187LymphocytosisSIDER
188Malignant neoplasm progressionOFFSIDES
189MalnutritionSIDER
190Manic psychosisSIDER
191MegacolonOFFSIDES
192MenorrhagiaSIDER
193Metabolic acidosisOFFSIDES
194MetrorrhagiaSIDER
195MonocytosisSIDER
196Morphine Dependence12065198CTD
197Muscle tightnessOFFSIDES
198Musculoskeletal chest painOFFSIDES
199Musculoskeletal discomfortSIDER
200Myoglobin blood increasedOFFSIDES
201MyopathySIDER
202Neck PainSIDER
203NephrolithiasisSIDER
204NervousnessSIDER
205NeuralgiaSIDER
206Neurologic Manifestations11076270CTD
207NocturiaSIDER
208Obsessive thoughtsOFFSIDES
209PalpitationsSIDER
210PancreatitisSIDER
211PanophthalmitisSIDER
212ParanoiaSIDER
213Paranoid reactionSIDER
214Performance status decreasedOFFSIDES
215PericarditisOFFSIDES
216PharyngitisSIDER
217Pharyngolaryngeal PainOFFSIDES
218PhlebitisSIDER
219PhotophobiaSIDER
220PneumoniaSIDER
221PolyuriaSIDER
222Potentiating drug interactionOFFSIDES
223Prescribed overdoseOFFSIDES
224Prothrombin time ratio decreasedOFFSIDES
225PsoriasisSIDER
226Psychomotor skills impairedOFFSIDES
227Pulmonary EmbolismSIDER
228Pulmonary radiation injuryOFFSIDES
229Reticulocyte count increasedOFFSIDES
230Rheumatoid ArthritisSIDER
231RhinitisSIDER
232Schizoaffective DisorderOFFSIDES
233SchizophreniaOFFSIDES
234Sensorimotor disorderOFFSIDES
235Sexual DysfunctionSIDER
236ShockSIDER
237Skin lesionOFFSIDES
238SomnolenceSIDER
239StomatitisSIDER
240Substance Withdrawal Syndrome18377703CTD
241SweatingSIDER
242SyncopeSIDER
243SynovitisOFFSIDES
244TensionSIDER
245ThirstSIDER
246ThrombocytopeniaSIDER
247ThrombophlebitisSIDER
248Tooth LossOFFSIDES
249TorticollisSIDER
250Unevaluable eventOFFSIDES
251Urinary IncontinenceSIDER
252Urinary tract infectionSIDER
253Urine output increasedSIDER
254Vascular insufficiencyOFFSIDES
255Ventricular FibrillationOFFSIDES
256VertigoSIDER
257Vesiculobullous rashSIDER
258Visual ImpairmentSIDER
259Visual disturbanceOFFSIDES
260colonoscopyOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.